6-118827925-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_017696.3(MCM9):c.1732+2T>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000215 in 1,398,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_017696.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- premature ovarian failure 10Inheritance: AD, AR Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics
- 46,XX ovarian dysgenesis-short stature syndromeInheritance: AR, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- male infertilityInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_017696.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MCM9 | NM_017696.3 | MANE Select | c.1732+2T>C | splice_donor intron | N/A | NP_060166.2 | |||
| MCM9 | NM_001378356.1 | c.1732+2T>C | splice_donor intron | N/A | NP_001365285.1 | ||||
| MCM9 | NM_001378357.1 | c.1732+2T>C | splice_donor intron | N/A | NP_001365286.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MCM9 | ENST00000619706.5 | TSL:5 MANE Select | c.1732+2T>C | splice_donor intron | N/A | ENSP00000480469.1 | |||
| MCM9 | ENST00000316316.10 | TSL:5 | c.1732+2T>C | splice_donor intron | N/A | ENSP00000314505.5 | |||
| MCM9 | ENST00000458674.2 | TSL:5 | c.206-1061T>C | intron | N/A | ENSP00000406576.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000133 AC: 2AN: 150126 AF XY: 0.0000124 show subpopulations
GnomAD4 exome AF: 0.00000215 AC: 3AN: 1398442Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 689754 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
46,XX ovarian dysgenesis-short stature syndrome Pathogenic:2
The splice donor c.1732+2T>C variant in the MCM9 gene has been reported previously in homozygous state in an individual(s) affected with Premature ovarian failure (Wood-Trageser et al., 2014). Loss of function variants has been previously reported to be disease-causing. For the above-mentioned reasons, this variant has been classified as Pathogenic.
Premature ovarian failure 1 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at